3-62078214-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000474889.6(PTPRG):āc.571A>Gā(p.Ile191Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,610,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000474889.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRG | NM_002841.4 | c.571A>G | p.Ile191Val | missense_variant | 5/30 | ENST00000474889.6 | NP_002832.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPRG | ENST00000474889.6 | c.571A>G | p.Ile191Val | missense_variant | 5/30 | 1 | NM_002841.4 | ENSP00000418112 | A1 | |
PTPRG | ENST00000295874.14 | c.571A>G | p.Ile191Val | missense_variant | 5/29 | 1 | ENSP00000295874 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000140 AC: 35AN: 249138Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134674
GnomAD4 exome AF: 0.000182 AC: 265AN: 1458558Hom.: 0 Cov.: 30 AF XY: 0.000164 AC XY: 119AN XY: 725598
GnomAD4 genome AF: 0.000131 AC: 20AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The c.571A>G (p.I191V) alteration is located in exon 5 (coding exon 5) of the PTPRG gene. This alteration results from a A to G substitution at nucleotide position 571, causing the isoleucine (I) at amino acid position 191 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at